Clinical Trial Update: A Screening Protocol to Assess Adults and Adolescents With Down Syndrome for Eligibility For Upcoming Study of RG1662 (Study BP27832)

View source ↗

Summary

The document describes a screening protocol to determine eligibility of adults and adolescents with Down syndrome for an upcoming Roche study of RG1662 (BP27832…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Down Syndrome

Drugs mentioned

• RG1662

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Down Syndrome | Status: COMPLETED